PPT-CFID Clinical COVID19 Webinar

Speakers Dr Jonathan Grein CedarsSinai Medical Center LA Dr Shariq Haider McMaster University Moderator Dr Curtis Cooper University of Ottawa Our Mission The Canadian Foundation for Infectious Diseases is a charitable organization committed to improving the health of Canadians and people worldwide through the support of research and dissemination of knowledge pertaining to the prevention diagnosis control and treatment of infectious diseases. cfcovid19@od.nih.gov NB: These slides can be found at https://commonfund.nih.gov/covid19 after the webinar. OutlineNIH Common Fund NOT015 NOSISome of our FAQsQuestions from audience The NIH Common F 11Medicare COVID19 Case A count of beneficiaries with a diagnosis of COVID19 on a claim or encounter record for We use the following International Classification of Diseases ICD Tenth Revision ICD10 d x0000x0000Page of Can the CLIA program approve an 1135 waiver for any of the CLIA Regulations during the public health emergencyhttps//wwwcmsgov/medicareproviderenrollmentandcertificationsurveycertifi To support a data-driven US response to the coronavirus pandemic public health authorities and HHS depend on key data elements reported efficiently and accurately using COVID19 data standards to infor OFFICE OF THE ASSISTANT SECRETARY FOR HEALTHGuidance Proposed Use of PointCare POC Testing Platforms for SARSCoVCOVID19Overview SARSCoV2 COVID19 Fact SheetSerological POC Tests Currently there are no US Department of Health and Human ServicesOffice of Inspector GeneralData BriefSeptember OEI-02-20-0 Key TakeawaysMedicare beneficiarieshospitalized with COVID19 were treated for a wide range of compl P-12 SCHOOL AND CHILD CARE COVID-19 GUIDANCEAUGUST 13 2021By law each local school system nonpublic school and child care program may set their own to determine the layered prevention strategieseg usi In response to the CDC recommendations for all healthcare facilities SAMHSA offers further considerationsspecific to psychiatric hospitalsReduce morbidity and mortalityx0000x0000 x/MCIxD 47x 000x/MCI This document provides recommendations and considerations for reducing transmission risk of COVID19 All sports teams and organizationsincluding recreationalandcommunity organizations youth and adult l A webinar sponsored by the FedEx Institute of Technology and School of Public Health at the University of Memphis. Deborah Moncrieff, Ph.D., CCC-A. Jennifer . P. . Taylor, . Au.D. .. School of Communication Sciences and Disorders. 1119 International Journal of Biological Sciences1119doi: 10.7150/ijbs59374viewAssessment of global asymptomatic SARSinfection andmanagement practices from ChinaChen, Bili Wang, Shanshan Maoand ing Ye RESPONSE: EMERGENCY ASSISTANCE & DEMAND COVID19 RENTAL RELIEF UPDATE: WEEK OF APR 25MAY 1 APPLICATIONS BY WEEK (ENDED 12/31 11,032 total applications(excluding 3,879 duplicate applications in grey) AP have more severe disease than olderchildren. It is also bereported from China that the risk to pregnant femalewith COVID19 are higher than those that are not infected. There is no evidence of vertical Accelerating Medicines Partnership®. Bespoke Gene Therapy Consortium (BGTC). 1. Clinical Subteam co-chairs. Susana Serrate-Sztein, MD (NIAMS/NIH). Ed Neilan, . MD, PhD (NORD). Program Management. Courtney Silverthorn, PhD (FNIH).